Efficacy of anlotinib in advanced soft tissue sarcoma by age, gender, and ECOG performance status.

被引:0
|
作者
Fang, Zhiwei
Yao, Yang
Cai, Jianqiang
Chi, Yihebali
Wang, Shusen
Huang, Gang
Cai, Qiqing
Shang, Guanning
Wang, Guowen
Qu, Guofan
Wu, Qiong
Jiang, Yu
Song, Jianmin
Chen, Jing
Cai, Zhengdong
Zhu, Xia
Bai, Chunmei
Lu, Yongkui
Yu, Zhihua
Shen, Jingnan
机构
[1] Beijing Canc Hosp, Beijing, Peoples R China
[2] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai, Peoples R China
[3] Canc Hosp, Dept Abdominal Surg, CAMS, Beijing, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China
[5] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[6] Hunan Canc Hosp, Changsha, Peoples R China
[7] Henan Canc Hosp, Zhengzhou, Peoples R China
[8] Liaoning Canc Hosp & Inst, Shenyang, Peoples R China
[9] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China
[10] Harbin Med Univ, Canc Hosp, Harbin, Peoples R China
[11] Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China
[12] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
[13] Gansu Prov Canc Hosp, Lanzhou, Peoples R China
[14] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China
[15] Shanghai Jiao Tong Univ, Peoples Hosp 1, Shanghai, Peoples R China
[16] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China
[17] Peking Union Med Coll Hosp, Beijing, Peoples R China
[18] Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Peoples R China
[19] Jiangxi Canc Hosp, Nanchang, Jiangxi, Peoples R China
[20] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e23562
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Age, Gender, Performance Status, and Symptom Prevalence in Advanced Cancer
    Walsh, Declan
    Rybicki, Lisa
    Kirkova, Jordanka
    Aktas, Aynur
    JOURNAL OF PALLIATIVE CARE, 2010, 26 (03) : 241 - 241
  • [32] A phase II study of anlotinib in the first-line treatment of locally advanced or metastatic soft tissue sarcoma.
    Huang, Xin
    Ye, Zhaoming
    Li, Tao
    Wei, Yongzhong
    Wang, Shoufeng
    Liu, Yunxia
    Chen, Jia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] MAID CHEMOTHERAPY FOR ADVANCED SOFT TISSUE SARCOMA
    Igarashi, Tadahiko
    Murayama, Kayoko
    Murata, Naoya
    Irisawa, Hiroyuki
    ANNALS OF ONCOLOGY, 2010, 21 : 38 - 38
  • [34] Aldoxorubicin for the treatment of advanced soft tissue sarcoma
    Sankhala, Kamalesh K.
    Chawla, Neal S.
    Chawla, Sant P.
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (04): : 457 - 466
  • [35] TREATMENT OF ADVANCED SOFT-TISSUE SARCOMA
    ROSENBAUM, C
    SCHOENFELD, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 287 - 287
  • [36] Systemic Therapy for Advanced Soft Tissue Sarcoma
    Sheng, Jennifer Y.
    Mowa, Sujana
    SURGICAL CLINICS OF NORTH AMERICA, 2016, 96 (05) : 1141 - +
  • [37] Treatment strategy for advanced soft tissue sarcoma
    Takahashi, Shunji
    ANNALS OF ONCOLOGY, 2017, 28 : 34 - 34
  • [38] Olaratumab in the management of advanced soft tissue sarcoma
    Zobniw, Chrystia M.
    Van Anh Trinh
    Posey, Kristi
    Somaiah, Neeta
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (02) : 442 - 448
  • [39] Olaratumab for the treatment of advanced soft tissue sarcoma
    Okuno, Scott H.
    Maran, Avudaiappan
    Robinson, Steven I.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (10) : 883 - 887
  • [40] Efficacy and safety of apatinib monotherapy in advanced bone and soft tissue sarcoma: An observational study
    Zhu, Baorang
    Li, Jing
    Xie, Qiaosheng
    Diao, Liyan
    Gai, Lvhua
    Yang, Wuwei
    CANCER BIOLOGY & THERAPY, 2018, 19 (03) : 198 - 204